Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
Immunotherapy
>>
Phase 3
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
8
16
24
32
40
48
56
64
72
80
Neupogen
(filgrastim) / Kyowa Kirin, Amgen
Opdivo
(nivolumab) / BMS
Yervoy
(ipilimumab) / BMS
Imfinzi
(durvalumab) / AstraZeneca
Leukine
(sargramostim) / Partner Therap
Xpovio
(selinexor) / Karyopharm
Tevimbra
(tislelizumab-jsgr) / BeiGene
Jemperli
(dostarlimab-gxly) / GSK
Fibromun
(onfekafusp alfa) / Philogen
Kinaction
(masitinib) / AB Science
CMB305
/ Merck (MSD)
Vigil
(gemogenovatucel-T) / Gradalis
socazolimab
(STI-A1014) / Sorrento
ID-LV305
/ Merck (MSD)
Enbrel
(etanercept) / Pfizer, Amgen
ViraferonPeg
(peginterferon-α-2b) / Merck (MSD)
ezabenlimab
(BI 754091) / Boehringer Ingelheim
